SEC Form 4 · accession 0001645627-17-000103
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Aug 2, 2017
Accepted (ET)
Aug 7, 2017 · 3:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 2, 2017 | P | 3,000 | $0.0299 | A | 22,144,389 | D | |
| Common Stock | Aug 2, 2017 | P | 3,000 | $0.0301 | A | 22,147,389 | D | |
| Common Stock | Aug 3, 2017 | P | 3,000 | $0.029 | A | 22,150,389 | D | |
| Common Stock | Aug 3, 2017 | P | 5,000 | $0.0285 | A | 22,155,389 | D | |
| Common Stock | Aug 3, 2017 | P | 5,000 | $0.028 | A | 22,160,389 | D | |
| Common Stock | Aug 3, 2017 | P | 2,000 | $0.028 | A | 22,162,389 | D | |
| Common Stock | Aug 3, 2017 | P | 5,000 | $0.0265 | A | 22,167,389 | D | |
| Common Stock | Aug 3, 2017 | P | 2,000 | $0.0265 | A | 22,169,389 | D | |
| Common Stock | Aug 3, 2017 | P | 2,000 | $0.0282 | A | 22,171,389 | D | |
| Common Stock | Aug 3, 2017 | P | 3,000 | $0.0283 | A | 22,174,389 | D | |
| Common Stock | Aug 3, 2017 | P | 2,000 | $0.0283 | A | 22,176,389 | D | |
| Common Stock | Aug 3, 2017 | P | 2,000 | $0.0281 | A | 22,178,389 | D | |
| Common Stock | Aug 3, 2017 | P | 5,000 | $0.028 | A | 22,183,389 | D | |
| Common Stock | Aug 4, 2017 | P | 1,105 | $0.0272 | A | 22,184,494 | D | |
| Common Stock | Aug 4, 2017 | P | 3,895 | $0.0279 | A | 22,188,389 | D | |
| Common Stock | Aug 4, 2017 | P | 3,000 | $0.027 | A | 22,191,389 | D | |
| Common Stock | Aug 4, 2017 | P | 3,000 | $0.027 | A | 22,194,389 | D | |
| Common Stock | Aug 4, 2017 | P | 3,000 | $0.027 | A | 22,197,389 | D |
Table II — derivative securities
No Table II lines on this filing.